Effects of 6-hydroxydopamine on the Expression of Iron Metabolism - Related Proteins in Primary Oligodendrocyte Progenitor Cells

Effects of 6-hydroxydopamine on the Expression of Iron Metabolism - Related Proteins in Primary Oligodendrocyte Progenitor Cells

Loading document ...
Loading page ...


Author(s): Chen Zhi-qiang, Li Na, Wang Jun

Download Full PDF Read Complete Article

DOI: 10.18483/ijSci.1429 143 493 82-84 Volume 6 - Sep 2017


Oligodendrocyte progenitor cells play an important role in the formation of myelin sheath and the protection of neurons. After the action of 6- hydroxy dopamine on primary oligodendrocyte progenitor cells, elevated iron regulatory proteins resulted in an increase in Transferrin Receptor-1 and a decrease in Ferroportin-1 in oligodendrocyte progenitor cells.The extracellular iron entering cells is mediated by TfR1 endocytosis. As the expression of Transferrin Receptor-1 increases, the large number of extracellular iron moves into oligodendrocyte progenitors, but the expression of Ferroportin-1 was decreased, the intracellular iron turnover decreased, increase of iron content in the cell. 6-hydroxydopamine acts on oligodendrocyte progenitor cells leading to changes in intracellular iron metabolism, so that oligodendrocyte progenitor cells increased iron content.


6-hydroxydopamine, Primary Oligodendrocyte Precursor, IRP1, FPN1, TfR1


  1. Pantopoulos, K., et al., Abnormal Brain Iron Metabolism in Irp2 Deficient Mice Is Associated with Mild Neurological and Behavioral Impairments. PLoS ONE, 2014. 9(6): p. e98072.
  2. Rouault, T.A., Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci, 2013. 14(8): p. 551-64.
  3. Dusek, P., J. Jankovic, and W. Le, Iron dysregulation in movement disorders. Neurobiol Dis, 2012. 46(1): p. 1-18.
  4. Zhu, Y., et al., Iron accumulation and microglia activation contribute to substantia nigra hyperechogenicity in the 6-OHDA-induced rat model of Parkinson's disease. Parkinsonism Relat Disord, 2017. 36: p. 76-82.
  5. Hirsch, E.C., Iron transport in Parkinson's disease. Parkinsonism Relat Disord, 2009. 15 Suppl 3: p. S209-11.
  6. Tauheed, A.M., J.O. Ayo, and M.U. Kawu, Regulation of oligodendrocyte differentiation: Insights and approaches for the management of neurodegenerative disease. Pathophysiology, 2016. 23(3): p. 203-10.
  7. Cavaliere, F., et al., Oligodendrocyte differentiation from adult multipotent stem cells is modulated by glutamate. Cell Death Dis, 2012. 3: p. e268.
  8. Poliak, S. and E. Peles, The local differentiation of myelinated axons at nodes of Ranvier. Nat Rev Neurosci, 2003. 4(12): p. 968-80.
  9. Fernandez-Castaneda, A. and A. Gaultier, Adult oligodendrocyte progenitor cells - Multifaceted regulators of the CNS in health and disease. Brain Behav Immun, 2016. 57: p. 1-7.
  10. Michalski, J.P. and R. Kothary, Oligodendrocytes in a Nutshell. Front Cell Neurosci, 2015. 9: p. 340.
  11. Annese, V., et al., Evidence of oligodendrogliosis in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism. Neuropathology and Applied Neurobiology, 2013. 39(2): p. 132-143.
  12. Marro, S., et al., Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position −7007 of the FPN1 promoter. Haematologica, 2010. 95(8): p. 1261-8.
  13. Milczarek, A., et al., A drastic superoxide-dependent oxidative stress is prerequisite for the down-regulation of IRP1: Insights from studies on SOD1-deficient mice and macrophages treated with paraquat. PLoS One, 2017. 12(5).

Cite this Article:

International Journal of Sciences is Open Access Journal.
This article is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) License.
Author(s) retain the copyrights of this article, though, publication rights are with Alkhaer Publications.

Search Articles

Issue June 2023

Volume 12, June 2023

Table of Contents

World-wide Delivery is FREE

Share this Issue with Friends:

Submit your Paper